Meet the TEAM

Chief Executive Officer

René is a seasoned life science professional, boasting over a quarter-century of experience in the pharmaceutical and health-tech industry. His extensive career has included pivotal roles at leading global companies such as GSK, Organon, Novartis, and Takeda.

In his previous role as Vice President of Global Franchises at Takeda, René exhibited exemplary leadership in both the Neuroscience and Cardiovascular & Metabolic (CVM) sectors, where his strategic insights were key to shaping and driving the company’s direction in these critical therapeutic areas.

With a track record spanning more than a decade, René is a recognized leader in the development of Digital Solutions. During his tenures at Novartis and Takeda, he was instrumental in crafting and implementing innovative Digital Medicine concepts, particularly in the realm of NeuroPsychiatric disorders. His visionary approach continues to push the boundaries of digital healthcare solutions.

Educationally, René holds a B.Sc. in Information Management from the University of Applied Sciences Larenstein. Beyond his formal education, he has further enriched his expertise through Executive Training in Finance from the esteemed Harvard Business School. This blend of technical and financial acumen positions René as a well-rounded leader, poised to navigate the complex landscape of the life sciences industry.

Chief Technology Officer

Charith, stands as an accomplished software architect with a robust experience of over 4 years in the technology industry. His journey showcases a blend of versatility and expertise, transforming concepts into tangible realities. As the lead developer of myAVOS, Charith’s contributions have been pivotal in shaping the app's innovative features and functionalities.

 From crafting elegant code to architecting comprehensive digital solutions, Charith’s career has been a trajectory of progressive leadership. His role as the lead developer of myAVOS highlights his exceptional ability to bring cutting-edge ideas to fruition.

Charith’s mastery extends across modern frontend technologies like ReactJs and VueJs. Additionally, he boasts hands-on experience in hybrid mobile app development with React Native and Flutter. Charith’s proficiency also shines through in backend development, where he excels in platforms like Django, Ruby on Rails, Express, and Spring Boot.

During his tenure at Optichronix, Charith showcased his prowess by leading the development of a significant portion of the application. He implemented a serverless backend using AWS services, OpenAI LLM and Vertex LLMs,  demonstrating his adeptness in data management, machine learning technology, network architecture, and security.

Charith’s stint at Ontera displayed his talent for hybrid desktop application development, utilizing ElectronJs. His designs, often incorporating intricate and synchronous workers for offline data synchronization, reflect a deep understanding of data integrity and availability in modern applications.

Educationally, Charith holds a Bachelor's Degree in Computer Science from Malla Reddy Institute of Engineering and Technology, Charith’s formal education laid the groundwork for his illustrious career. 

Charith’s technology philosophy revolves around making software work for people. 

Chief Medical Director

Roger, a highly experienced and dedicated medical professional, began his remarkable career in 1981 when he qualified in medicine. His initial years were marked by diverse clinical roles in surgery, medicine, and A&E, laying a solid foundation for his career. In 1987, he embarked on specialized training in psychiatry, which lasted until 1990.

With a specialization in geriatric psychiatry, Roger’s profound expertise has served as a cornerstone in his roles as an NHS Consultant, which he upheld from 1993 until 2013.

In 1994, Roger founded the Kingshill Research Centre, nurturing it from its inception into a prestigious national and international facility under his capable leadership.

As a testament to his commitment to advancing the field, Roger has served as the UK coordinating investigator on numerous occasions. His extensive contributions to academic literature include the publication of over 100 peer-reviewed papers, several noteworthy books, and a host of chapters in various publications.

For eight years, Roger devoted his expertise to educating the next generation of psychiatrists as a clinical tutor. Additionally, he spent four enriching years serving as the Academic Secretary of the Royal College of Psychiatrists' Faculty of Old Age Psychiatry, a role in which his guidance was invaluable. Recognized for his expertise and contributions, Roger has been an invited speaker at numerous national and international conferences, shedding light on important issues in geriatric psychiatry.

In addition to his clinical and academic achievements, Roger has a distinguished history in healthcare management. For 11 significant years, he held senior management positions within the NHS, with his last six years as the Clinical Director of Older People's Services. In this pivotal role, he was successfully responsible for a £55 million budget and the clinical governance of a staff of 800—a testament to his exceptional leadership and managerial prowess.

Roger’s exemplary career is marked by a commitment to patient care, academic excellence, and healthcare leadership. His contributions to geriatric psychiatry are respected and acknowledged both nationally and internationally.

Financial Officer

Anna is a seasoned professional with a wealth of experience in controlling, strategy, and risk management, honed within the fast-paced and competitive environment of global fast-moving consumer goods (FMCG) companies. Her deep understanding of business dynamics, coupled with her strategic mindset, has made her a standout leader in her field.

In her current role, Anna holds the esteemed position of Head of the Basel Section and serves as a Board Member for the Swiss Hospital Service of the Order of Malta. In these capacities, she plays a pivotal role in shaping and steering a key healthcare institution in Switzerland, evidencing her leadership beyond the corporate world and into the realms of service and philanthropy.

Educationally, Anna is a distinguished alumna with an M.Sc. in International Management/CEMS, which she earned cum laude from the prestigious Rotterdam School of Management. Her quest for knowledge and excellence did not stop there; she has further refined her leadership skills through executive education programs at IMD Lausanne and IESE Business School, two of Europe’s premier institutions for business education.

Beyond her formal roles and education, Anna's commitment to nurturing talent and contributing to positive global change is further demonstrated through her involvement with prominent development initiatives. She is an alumna of Evonik’s RISE Talent Program, a platform designed to cultivate high-potential leaders within the organization. Moreover, as a One Young World Ambassador, Anna engages with a network of young leaders from around the globe, advocating for impactful and responsible leadership.

Regs and Compliance Officer

Albrecht stands as a transformational leader, with an international career spanning over two decades at the critical intersection of science, policy, and regulation. His extensive experience has been honed in the fast-paced and high-growth environments of Biotech and FMCG (Fast Moving Consumer Goods) industries.

Deeply knowledgeable in national and supranational regulation, Albrecht is a trusted authority on the governance of both consumer products and non-food items. His expertise is not just theoretical; it is grounded in substantial, hands-on experience navigating complex regulatory landscapes across various jurisdictions.

As a seasoned professional, Albrecht has an impressive history of conducting, directing, commissioning, and publishing scientific and clinical research of the highest caliber. His work is distinguished not only by its rigor but also by its impact, as he has been instrumental in forging first-in-class partnerships with NGOs and strategic collaborations with government-owned research organizations. These partnerships have been pivotal in advancing evidence-informed approaches to public health policy and practice, showcasing Albrecht's commitment to leveraging science for the betterment of society.

Educationally, Albrecht holds a Ph.D. in Natural Sciences from the esteemed University of Göttingen. Further complementing his scientific acumen, he has earned an MBA from the Anaheim University Akio Morita School of Business. His commitment to continuous learning and excellence is further demonstrated by postgraduate certificates from the renowned Oxford and Hull universities.

With a career defined by innovation, leadership, and a tireless pursuit of knowledge, Albrecht exemplifies what it means to be at the forefront of science and policy in today’s rapidly evolving global landscape.

Corporate Secretary

Mark is a distinguished legal professional with an impressive career spanning 27 years, marked by global experience and a deep expertise in corporate law. His career journey showcases a variety of pivotal roles, including serving as the Vice President and General Counsel of Butamax® Advanced Biofuels LLC, a joint venture between industry giants BP and DuPont.

In this capacity, Mark was not merely a legal executive; he was a strategic advisor, safeguarding the company’s interests while steering its legal and regulatory path through the complex biofuels landscape.

Mark's leadership capabilities were further demonstrated during his tenure as General Counsel and Compliance Officer at Ilera Healthcare, a successful startup where he played a significant role in establishing a strong legal and compliance framework that supported the company’s rapid growth and innovation.

With an impressive 13-year service as the Corporate Intellectual Property Litigation Counsel for DuPont’s strategic businesses, Mark’s vast experience encompasses not only intellectual property law but also an extensive track record in technology, licensing, and commercial transactions. His robust legal strategies have continuously proven to be instrumental in securing and protecting critical intellectual assets for the companies he has served.

As a Registered U.S. Patent Attorney with the United States Patent and Trademark Office, Mark’s skills extend beyond traditional legal counsel. He is adept at navigating the intricate web of patent law, ensuring his clients are expertly guided in safeguarding their innovations. This unique perspective also makes him a sought-after Intellectual Property consultant for startups and emerging companies, for whom he acts as both a protector of innovations and a strategic advisor.

Educationally, Mark holds a B.A. in Chemistry from Kenyon College, showcasing a technical foundation that complements his legal prowess. This blend of scientific insight and legal expertise equips Mark with a uniquely comprehensive perspective, enabling him to adeptly navigate the multifaceted challenges of the legal realm in the technological and scientific industries.

In summary, Mark is not just a legal expert; he is a strategic partner, guiding organizations through complex legal terrain with a clear vision, steadfast resolve, and a wealth of experience that sets him apart as a leader in his field.